GRAIL, Inc. Common Stock
GRALStock
$71.96+92.99%52W
Market Cap$3.19B
P/E—
Div yield—
Beta2.26
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-37.68%
Price vs S&P 500 (4W)26.97%
VGM Score60.57
Market Capitalization$3.19B
Earnings Surprise History
Q1 26-2.29est. -2.82
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.08
3.93
3.93
3.87
Industry Peers — Health Services(29)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
GRALGRAIL, Inc. Common Stock | D | A | B | $71.96 |
| NTRANatera, Inc. Common Stock | F | A | B | $269.83 |
| DGXQuest Diagnostics Inc. | C | D | C | $209.41 |
| LHLabcorp Holdings Inc. | C | D | C | $281.94 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $155.00 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | B | $128.18 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $62.99 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.48 |
| VCYTVeracyte, Inc. | D | A | A | $59.22 |
| CELCCelcuity Inc. Common Stock | — | — | B | $88.29 |
About
GRAIL Inc develops a blood-based test for multi-cancer early detection designed to identify various cancer types at earlier stages. The company provides testing services focused on enabling earlier diagnosis and intervention, operating as a single business segment dedicated to cancer detection technology.